
A new $6.4 billion lawsuit against Bristol Myers Squibb Co (BMY.N) in Manhattan Federal Court accuses the firm of delaying lymphoma cancer drugs to avoid paying Celgene Corp's shareholders, avoiding a "milestone" payment. Bristol Myers Squibb, which purchased the drug manufacturer Celgene Corporation in 2019, was slapped with the lawsuit... Read More »